Sanofi gets CDSCO marketing nod for RSV treatment Beyfortus in India Ruchika Sharma1 Aug 2024 5:30 PM ISTDrugmaker, Sanofi India, has received marketing authorisation approval from the Central Drugs Standard Control Organisation (CDSCO) for Beyfortus in...
GSK pharma Gets CDSCO Panel Nod To study Respiratory Syncytial Virus vaccine RSVPreF3 OA Dr. Divya Colin10 Jun 2024 6:00 PM ISTNew Delhi: Advising to include clinical trial sites from various states in the southern part of India, the Subject Expert Committee (SEC) functional...
Sanofi Gets CDSCO Panel Nod To Import, Market Nirsevimab to Treat Respiratory Syncytial Virus Disease Dr. Divya Colin27 March 2024 6:00 PM ISTNew Delhi: Pharmaceutical major Sanofi Healthcare India has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug...
First Vaccine for Pregnant Individuals to Prevent RSV in Infants approved by FDA Dr. Kamal Kant Kohli22 Aug 2023 12:00 PM ISTRespiratory Syncytial Virus is a highly contagious virus that causes respiratory infections in individuals of all age groups. Furthermore it is the...
GSK gets positive EMA panel opinion for Respiratory syncytial virus older adult vaccine Ruchika Sharma29 April 2023 2:30 PM ISTGSK's RSV older adult vaccine candidate contains a recombinant subunit RSV prefusion F glycoprotein antigen (RSVPreF3) combined with the Company's...
